Hologic (HOLX) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4364401012

Medical Imaging Systems, Diagnostic Assays, Surgical Systems, Breast Cancer Care Solutions

Hologic, Inc. is a leading healthcare company that specializes in developing, manufacturing, and supplying innovative products and solutions for women's health, diagnostics, and medical imaging. The company's mission is to enable early detection and treatment of various health conditions, improving the lives of millions of people worldwide.

The company operates through four main business segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Its Diagnostics segment offers a range of molecular diagnostic assays, including Aptima, which detects infectious microorganisms, such as Hepatitis B and C, HIV, and SARS-CoV-2. These assays help healthcare professionals diagnose and monitor diseases more accurately and efficiently.

In the Breast Health segment, Hologic provides a comprehensive range of solutions for breast cancer care, including 3D digital mammography systems, image analytics software, and minimally invasive breast biopsy guidance systems. These products enable healthcare professionals to detect breast cancer earlier and more accurately, improving treatment outcomes for patients.

The GYN Surgical segment offers a range of products for gynecological surgical procedures, including the MyoSure Hysteroscopic Tissue Removal System, NovaSure Endometrial Ablation System, and Fluent Fluid Management System. These products are designed to improve patient outcomes and reduce recovery time.

In the Skeletal Health segment, Hologic offers the Horizon DXA, a dual energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which enables minimally invasive orthopedic surgical procedures. These products help healthcare professionals diagnose and treat bone-related disorders more effectively.

Hologic sells its products through a combination of direct sales, service forces, independent distributors, and sales representatives. With a strong commitment to innovation and customer satisfaction, Hologic has established itself as a trusted partner for healthcare professionals worldwide.

Headquartered in Marlborough, Massachusetts, Hologic, Inc. was founded in 1985 and has since become a global leader in the healthcare industry. For more information, please visit their website at https://www.hologic.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Hologic (HOLX) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Hologic (HOLX) - Stock Price & Dividends

HOLX Stock Overview

Market Cap in USD 17,263m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1990-06-21

HOLX Stock Ratings

Growth 5y 34.2
Fundamental 47.9
Dividend -
Rel. Performance vs Sector -2.33
Analysts 3.82/5
Fair Price Momentum 66.16 USD
Fair Price DCF 111.44 USD

HOLX Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

HOLX Growth Ratios

Growth 12m -10.30%
Growth Correlation 12m 4%
Growth Correlation 3m -68%
CAGR 5y 8.51%
CAGR/Mean DD 5y 0.75
Sharpe Ratio 12m -0.86
Alpha vs SP500 12m -33.94
Beta vs SP500 5y weekly 0.83
ValueRay RSI 44.40
Volatility GJR Garch 1y 15.83%
Price / SMA 50 -2.29%
Price / SMA 200 0.33%
Current Volume 2048.9k
Average Volume 20d 1359.5k

External Links for HOLX Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of HOLX stocks?
As of June 22, 2024, the stock is trading at USD 73.07 with a total of 2,048,929 shares traded.
Over the past week, the price has changed by +1.78%, over one month by -1.99%, over three months by -3.24% and over the past year by -10.27%.
What are the forecast for HOLX stock price target?
According to ValueRays Forecast Model, HOLX Hologic will be worth about 72.9 in June 2025. The stock is currently trading at 73.07. This means that the stock has a potential downside of -0.21%.
Issuer Forecast Upside
Wallstreet Target Price 86.6 18.5
Analysts Target Price 86.6 18.5
ValueRay Target Price 72.9 -0.21